Thomas F. Miller insider trades

Open-market stock purchases and sales by Thomas F. Miller, Chief Executive Officer at Iambic Therapeutics, Inc, from SEC Form 4 filings since Sep 3, 2024.

Recent trades

DateStockTradeValue
Oct 14, 2026IAM Iambic Therapeutics, IncBought (not open market)—
Oct 14, 2026IAM Iambic Therapeutics, IncBought (not open market)—
Jun 11, 2026VCYT Veracyte, IncBought (not open market)—

Companies traded

  • IAM Iambic Therapeutics, Inc: other filings, last Oct 14, 2026
  • VCYT Veracyte, Inc: other filings, last Jun 11, 2026

Get free alerts when Thomas F. Miller files a new trade →